Manuscripts

Search by keyword, year, or author name.

Showing 1556 manuscripts.

A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain

Scott Evans, David M. Simpson, Doug Kitch, Agnes King, David B. Clifford, Bruce A. Cohen, Justin C. McArthur. A randomized trial evaluating Prosaptide for HIV-associated sensory neuropathies: use of an electronic diary to record neuropathic pain. Public Library of Science Clinical Trials. 2007. 2: e551.

Year

2007

Journal

Public Library of Science Clinical Trials

Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384

Michael P. Dube, Lauren Komarow, Kathleen Mulligan, Steven K. Grinspoon, Robert A. Parker, Gregory K. Robbins, Ronenn Roubenoff, Pablo Tebas. Long-term body fat outcomes in antiretroviral-naive participants randomized to nelfinavir or efavirenz or both plus dual nucleosides. Dual X-ray absorptiometry results from A5005s, a substudy of adult clinical trials group 384. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 508-14.

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes

Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study

Junfeng Sun, Haikady N. Nagaraja, Nancy Radcliffe Reynolds. Discrete stochastic models for compliance analysis based on an AIDS Clinical Trial Group (ACTG) study. Biometrics. 2007. 49: 731-41.

Year

2007

Journal

Biometrics

Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV

Grace McComsey, Michelle A. Kendall, Pablo Tebas, Susan Swindells, Evelyn Hogg, Beverly L. Alston-Smith, Carol Suckow, Geetha Gopalakrishnan, Constance A. Benson, David Alain Wohl. Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV. AIDS. 2007. 21: 2473-82.

Year

2007

Journal

AIDS

Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384

Michael P. Dube, Robert A. Parker, Kathleen Mulligan, Pablo Tebas, Gregory K. Robbins, Ronenn Roubenoff, Steven K. Grinspoon. Effects of potent antiretroviral therapy on free testosterone levels and fat-free mass in men in a prospective, randomized trial: A5005s, a substudy of AIDS Clinical Trials Group Study 384. Clinical Infectious Diseases. 2007. 45: 120-6. PMID: 17554712

Year

2007

Journal

Clinical Infectious Diseases

Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations

B. Healy, Victor DeGruttola, Marcello Pagano. Combining cross-sectional and prospective data methods to improve transition parameter estimation for characterizing the accumulation of HIV-1 drug resistance mutations. Biometrics. 2007. 63: 742-50.

Year

2007

Journal

Biometrics

Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase

Zixin Hu, Hiroyu Hatano, Scott Hammond, Danielle Smith, Mary Wild, Soumi Gupta, Jeannette M. Whitcomb, Robert C Kalayjian, Barbara Gripshover, Daniel R. Kuritzkes. Virologic characterization of HIV type 1 with a codon 70 deletion in reverse transcriptase. Journal of Acquired Immune Deficiency Syndromes. 2007. 45: 494-500. PMID: 17496561

Year

2007

Journal

Journal of Acquired Immune Deficiency Syndromes